Zoetis

US98978V1035

ZTS

ZTS

Moin Moin,

all values fit except of course $NVDA (+3,67 %) I have topped up another 4 k which will arrive tomorrow and will then be invested directly.

The selection now stands at 10x $JNJ (-1,21 %) 10x $ZTS (-2,04 %) the rest into the ETF.

I want to go slowly all in all into the plus (still 200€ minus) through the values I think this will be easily feasible.

I'm only unsure about $ABR (-0,19 %) unsure, have so much loss already by the nice, either sell at a loss or wait until the fall, there should be the 3 (decisive phase whether it will hop or top) of 4 phases.

Does anyone have any ideas or improvements?

$TLRY (-0,62 %) will be sold again when they get to 2€.

Hello stock market friends,

I would be interested in your assessment of my Quality Growth portfolio.

I currently feel comfortable with the portfolio, even though it is very technology-focused.

My approach is to only buy absolute quality companies with positive growth prospects at fair valuations. Some companies are simply rarely available at fair valuations ($ANET (+2,74 %)
$SNPS (+1,89 %) and co.), which is why I am prepared to add such companies with strong moats to my portfolio at a premium.

I am currently considering whether $MSCI (+0,28 %) after the market punished the last quarterly figures.

I am also keeping a closer eye on $ZTS (-2,04 %) more closely due to the recent setbacks. Fundamentally, the company is still operating excellently and is starting to look more attractively valued than it did a few months ago.

What stocks do you know that could be a good addition to my portfolio?

LG

I know that advertising is not welcome here😉 but if you want you can watch my new video about $ZTS (-2,04 %) . After the recent price drop, I think they are relatively fairly and interestingly valued. What do you think of Zoetis?

https://youtu.be/1mnNUpEexew

$ZTS (-2,04 %) You are close to the 52-week low, if the support holds it may go up again. Pros are the high market value, the company makes a profit and pays dividends. Cons are the fundamental data such as P/E ratio and P/B ratio. I will take a look at $ELAN (+2,43 %) , $PETS (+3,99 %)
$PETQ (-0,36 %) in the watchlist

New addition to the depot: Zoetis

While classic pharmaceutical stocks should be well known to most, animal health is less in the spotlight.

#zoetis Zoetis is the global market leader here with medicines, vaccines, diagnostics, etc.

In recent years, a significant premium has always been paid, but this is comparatively low due to recent sales.

I therefore saw an entry opportunity and built up an initial position.

Animal health is a megatrend, as pets are becoming increasingly humanized. Pets are being treated like "real"/human family members - in the truest sense of the word.

I also see a strong positioning in the face of possibly more persistent inflation, as fewer savings are being made on pets.

At the latest at $130, I would increase significantly.

How do you rate the company? How do you see the short/medium/long-term prospects?